SUSMED,Inc. (4263.T)
Tokyo · JPY · Healthcare · Health Information Services
¥344 (-1.43%) as of
Key statistics
- Market cap
- 5.80B
- Forward P/E
- 20.85
- EPS (TTM)
- -22.71
- Dividend yield
- 0.00%
- 52-week range
- 340.00 – 1,231.00
- Beta
- 1.14
- Revenue (TTM)
- 497M
- Profit margin
- -76.86%
- Volume
- 105.00k
About SUSMED,Inc.
SUSMED,Inc. develops and sells therapeutic applications and platform systems in Japan. It operates through DTx product business, and DTx platform business segments. The company develops smartphone-based therapeutic apps for diseases, such as insomnia, breast cancer, and kidney disease. It also develops and provides clinical trial systems with blockchain technology. In addition, the company offers medical data analysis and consulting services. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- Tokyo, Japan
- Employees
- 50
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.